Treeline
Medicines, elevated
2025
Treeline Biosciences is a clinical-stage biopharmaceutical company founded by Josh Bilenker and Jeff Engelman, developing small molecules and targeted protein degraders for cancer. Backed by more than $1 billion in private funding, the company moved its first programmes into Phase 1 while still largely out of public view. G—W built the brand foundation, messaging, visual identity, website and brand extensions.
Next caseNabla BioHumanizing AI-native biotech
Treeline Biosciences is a clinical-stage biopharmaceutical company founded by Josh Bilenker and Jeff Engelman, developing small molecules and targeted protein degraders for cancer. Backed by more than $1 billion in private funding, the company moved its first programmes into Phase 1 while still largely out of public view. G—W built the brand foundation, messaging, visual identity, website and brand extensions.
Next caseNabla BioHumanizing AI-native biotech